Celldex Therapeutics Inc (CLDX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $30.64
• Market Cap: $2.05B
• EPS: $-3.38
• 52-Week High: $31.00
• 52-Week Low: $14.40

Market Sentiment

Celldex Therapeutics Inc currently has a Bullish sentiment score of 0.17.

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc. (CLDX) is a forward-thinking biopharmaceutical company headquartered in Hampton, New Jersey, dedicated to developing innovative therapeutic monoclonal and bispecific antibodies that target significant unmet medical needs in oncology and neurology. With a strong focus on proprietary technologies that enhance both the efficacy and safety profiles of its therapies, Celldex boasts a promising pipeline of clinical programs that underscore its leadership position in targe...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Celldex Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CLDX pay dividends?

Celldex Therapeutics Inc (CLDX) does not currently pay a regular dividend.

What is CLDX's market cap?

Celldex Therapeutics Inc (CLDX) has a market capitalization of $2.05B with a current stock price of $30.64.